These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30143982)

  • 1. Ensuring Product Quality, Consistency and Patient Supply over Time for a Large-Volume Biologic: Experience with Remicade
    Melsheimer R; Calmann M; DeRitis A; Philip V; Van Gog F; Doolittle L; Goyal K; Neblock D
    BioDrugs; 2018 Oct; 32(5):405-414. PubMed ID: 30143982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drift, evolution, and divergence in biologics and biosimilars manufacturing.
    Ramanan S; Grampp G
    BioDrugs; 2014 Aug; 28(4):363-72. PubMed ID: 24567263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Product quality considerations for mammalian cell culture process development and manufacturing.
    Gramer MJ
    Adv Biochem Eng Biotechnol; 2014; 139():123-66. PubMed ID: 23748351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to Quality Risk Management When Using Single-Use Systems in the Manufacture of Biologics.
    Ishii-Watabe A; Hirose A; Katori N; Hashii N; Arai S; Awatsu H; Eiza A; Hara Y; Hattori H; Inoue T; Isono T; Iwakura M; Kajihara D; Kasahara N; Matsuda H; Murakami S; Nakagawa T; Okumura T; Omasa T; Takuma S; Terashima I; Tsukahara M; Tsutsui M; Yano T; Kawasaki N
    AAPS PharmSciTech; 2015 Oct; 16(5):993-1001. PubMed ID: 26288941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety assurance for biologics manufactured in mammalian cell cultures: a multitiered strategy.
    Chen D
    Adv Biochem Eng Biotechnol; 2014; 139():167-83. PubMed ID: 23719711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA perspective on specifications for biotechnology products--from IND to PLA.
    Murano G
    Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of gene therapy products and the impact of manufacturing changes on product comparability.
    Simek SL
    Dev Biol (Basel); 2005; 122():139-44. PubMed ID: 16375258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manufacturing of biodrugs: need for harmonization in regulatory standards.
    Sahoo N; Choudhury K; Manchikanti P
    BioDrugs; 2009; 23(4):217-29. PubMed ID: 19697964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of Plate Imaging for Demonstration of Monoclonality in Biologics Manufacturing Development.
    Zingaro K; Shaw D; Carson J; Mayer-Bartschmid A; Bender C; Alves C; Mcvey D; Qian NX; Wei Q; Laird MW; Zhu Y; Emmins R; Follit JA; Porter A; Racher AJ; Milne S; Carubelli I; Du Z; Khatri A; Failly M; Broly H; Lee F; Reeser M; Spidel J; Anderson K; Demaria C; Di-Carlo J; Gill J; Lundquist A; Kumar SR; Gill T
    PDA J Pharm Sci Technol; 2018; 72(4):438-450. PubMed ID: 29669815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing.
    Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL
    PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing shortages of biologic medicines.
    Ramanan S; Grampp G
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):151-9. PubMed ID: 24386902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of a cell culture manufacturing process using quality by design (QbD) principles.
    Marasco DM; Gao J; Griffiths K; Froggatt C; Wang T; Wei G
    Adv Biochem Eng Biotechnol; 2014; 139():93-121. PubMed ID: 23828505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remicade
    Melsheimer R; Geldhof A; Apaolaza I; Schaible T
    Biologics; 2019; 13():139-178. PubMed ID: 31440029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manufacturing history of etanercept (Enbrel
    Hassett B; Singh E; Mahgoub E; O'Brien J; Vicik SM; Fitzpatrick B
    MAbs; 2018 Jan; 10(1):159-165. PubMed ID: 29020515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiproduct Resin Reuse for Clinical and Commercial Manufacturing-Methodology and Acceptance Criteria.
    Sharnez R; Doares S; Manning S; Mehta K; Mahajan E; To A; Daniels W; Glynn J; Dhamane S; Wen X; Wang Y; Gour P; Guenther C; Foley D; Hayes R; Mott A; Prabhu S; Tavalsky D; Hendershot M; Haas D; Hesslein A; Schuelke N; Tjandra H
    PDA J Pharm Sci Technol; 2018; 72(6):584-598. PubMed ID: 30030349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.
    Marini JC; Sendecki J; Cornillie F; Popp JW; Black S; Blank M; Gils A; Van Stappen T; Hamann D; Rispens T; Thérien L; Chun K; Shankar G
    AAPS J; 2017 Jan; 19(1):161-171. PubMed ID: 27600137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing unexpected events in the manufacturing of biologic medicines.
    Grampp G; Ramanan S
    BioDrugs; 2013 Aug; 27(4):305-16. PubMed ID: 23529766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.